Methods and systems for purifying noncomplexed botulinum neurotoxin

Details for Australian Patent Application No. 2010310749 (hide)

Owner Revance Therapeutics, Inc.

Inventors Ruegg, Curtis L.

Agent Freehills

Pub. Number AU-A-2010310749

PCT Pub. Number WO2011/050072

Priority 61/253,810 21.10.09 US

Filing date 20 October 2010

Wipo publication date 28 April 2011

International Classifications

C02F 1/28 (2006.01) Treatment of water, waste water, or sewage - by sorption

B01D 15/00 (2006.01) Separating processes involving the treatment of liquids with solid sorbents

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/050072 Priority application(s): WO2011/050072

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310750-Self-aligned barrier and capping layers for interconnects

2010310748-Isolation and purification of anti-IL-13 antibodies using Protein A affinity chromatography